Chronic renin inhibition with aliskiren improves glucose tolerance, insulin sensitivity, and skeletal muscle glucose transport activity in obese Zucker rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 302, Issue 1, 2012, Pages

  Marchionne, Elizabeth M ^a   Diamond Stanic, Maggie K ^a   Prasonnarong, Mujalin ^a   Henriksen, Erik J ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Glucose transport activity; Insulin resistance; Insulin signaling; Obesity; Renin angiotensin system

Indexed keywords

ALISKIREN; FATTY ACID; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; FEMALE; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; INSULIN RESISTANCE; INSULIN SENSITIVITY; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHOSPHORYLATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SKELETAL MUSCLE; SOLEUS MUSCLE; SYSTOLIC BLOOD PRESSURE; UPREGULATION; ZUCKER RAT;

AMIDES; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD PRESSURE; BODY WEIGHT; DISEASE MODELS, ANIMAL; FATTY ACIDS, NONESTERIFIED; FEMALE; FUMARATES; GLUCOSE; INSULIN; INSULIN RESISTANCE; MUSCLE, SKELETAL; OBESITY; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, ZUCKER; RENIN; SIGNAL TRANSDUCTION;

EID: 84255184279     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00448.2011     Document Type: Article

References (32)

1. Centers for Disease Control, and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
2. Cortez MY, Torgan CE, Brozinick JT, Ivy JL. Insulin resistance of obese Zucker rats exercise trained at two different intensities. Am J Physiol Endocrinol Metab 261: E613-E619, 1991.
3. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194, 1991.
4. Diamond-Stanic MK, Henriksen EJ. Direct inhibition by angiotensin II of insulin-dependent glucose transport activity in mammalian skeletal muscle involves a ROS-dependent mechanism. Arch Physiol Biochem 116: 88-95, 2010.
5. Dietze GJ, Henriksen EJ. Angiotensin I-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis. J Renin Angiotensin Aldosterone Syst 9: 75-88, 2008.
6. Dokken BB, Sloniger JA, Henriksen EJ. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in pre-diabetic insulin-resistant rat skeletal muscle. Am J Physiol Endocrinol Metab 288: E1188-E1194, 2005.
7. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103: 253-259, 1999.
8. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among U.S. adults, 1999-2008. JAMA 303: 235-241, 2010.
9. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48: 1270-1274, 1999.
10. Gulve EA, Henriksen EJ, Rodnick KJ, Youn JH, Holloszy JO. Glucose transporters and glucose transport in skeletal muscles of 1 to 25 month old rats. Am J Physiol Endocrinol Metab 264: E319-E327, 1993.
11. Habibi J, Whaley-Connell A, Hayden MR, DeMarco VG, Schneider R, Sowers SD, Karuparthi P, Ferrario CM, Sowers JR. Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat. Endocrinology 149: 5643-5653, 2008.
12. Hansen PA, Gulve EA, Holloszy JO. Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. J Appl Physiol 76: 979-985, 1994.
13. Henriksen EJ. Effects of acute exercise and exercise training on insulin resistance. J Appl Physiol 93: 788-796, 2002.
14. Henriksen EJ. Improvement of insulin sensitivity by antagonism of the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 293: R974-R980, 2007.
15. Henriksen EJ, Jacob S. Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism 44: 267-272, 1995.
16. Henriksen EJ, Jacob S, Kinnick TR, Teachey MK, Krekler M. Selective angiotensin II receptor receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension 38: 884-890, 2001.
17. Ismail H, Mitchell R, Samy MI. Pleiotropic effects of inhibitors of the RAAS in the diabeteic population: Above and beyond blood pressure lowering. Curr Diab Rep 10: 32-36, 2010.
18. Lastra G, Habibi J, Whaley-Connell AT, Manrique C, Hayden MR, Rehmer J, Patel K, Ferrario C, Sowers JR. Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression. Endocrinology 150: 2561-2568, 2009.
19. Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 144: 2179-2183, 2003.
20. Manrique C, Lastra G, Gardner M, Sowers JR. The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress. Med Clin North Am 93: 569-582, 2009.
21. Mathé D. Dyslipidemia and diabetes: animal models. Diabete Metab 21: 106-111, 1995.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
23. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harboring the Ren-2 gene. Nature 344: 541-544, 1990.
24. Ogihara T, Asano T, Katsuyuki A, Chiba Y, Sakoda H, Anai M, Shojima N, Ono J, Onishi Y, Fujishiro M, Katagiri H, Fukushima Y, Kikuchi M, Noguchi N, Aburatani H, Komuro I, Fujita T. Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling. Hypertension 40: 872-879, 2002.
25. Reddy KJ, Singh M, Bangit JR, Batsell RR. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review. J Cardiovasc Med 11: 633-647, 2010.
26. Shepherd PR, Kahn BB. Glucose transporters and insulin action- implications for insulin resistance and diabetes mellitus. N Engl J Med 341: 248-257, 1999.
27. Steen MS, Foianini KR, Youngblood EB, Kinnick TR, Jacob S, Henriksen EJ. Interactions of exercise training and ACE inhibition on insulin action in obese Zucker rats. J Appl Physiol 86: 2044-2051, 1999.
28. Taube A, Eckardt K, Eckel J. Role of lipid-derived mediators in skeletal muscle in insulin resistance. Am J Physiol Endocrinol Metab 297: E1004-E1012, 2009.
29. Van den Meiracker AH, Jan Danser AH. Aliskiren: the first direct renin inhibitor for hypertension. Curr Cardiol Rep 9: 470-476, 2007.
30. Wei Y, Sowers JR, Nistala R, Gong H, Uptergrove GM, Clark SE, Morris EM, Szary N, Manrique C, Stump CS. Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. J Biol Chem 281: 35137-35146, 2006.
31. Wood JM, Schnell CR, Cumin F, Menard J, Webb RL. Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats. J Hypertens 23: 417-426, 2005.
32. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Shulman GI. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277: 50230-50236, 2002.